PROVECTUS BIOPHARMACEUTICALS, INC. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Provectus Biopharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Provectus Biopharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -220 %, a 32.6% decline year-over-year.
  • Provectus Biopharmaceuticals, Inc. annual Return On Assets for 2023 was -190 %, a 23.8% decline from 2022.
  • Provectus Biopharmaceuticals, Inc. annual Return On Assets for 2022 was -153 %, a 63% increase from 2021.
  • Provectus Biopharmaceuticals, Inc. annual Return On Assets for 2021 was -414 %, a 28.8% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -190 -36.4 -23.8% Jan 1, 2023 Dec 31, 2023
2022 -153 +261 +63% Jan 1, 2022 Dec 31, 2022
2021 -414 +168 +28.8% Jan 1, 2021 Dec 31, 2021
2020 -582 -289 -98.5% Jan 1, 2020 Dec 31, 2020
2019 -293 +3.67 +1.24% Jan 1, 2019 Dec 31, 2019
2018 -297 +26.6 +8.23% Jan 1, 2018 Dec 31, 2018
2017 -323 -96.8 -42.7% Jan 1, 2017 Dec 31, 2017
2016 -226 -129 -134% Jan 1, 2016 Dec 31, 2016
2015 -97 -51.8 -115% Jan 1, 2015 Dec 31, 2015
2014 -45.2 +170 +79% Jan 1, 2014 Dec 31, 2014
2013 -215 -63.6 -41.9% Jan 1, 2013 Dec 31, 2013
2012 -152 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.